G2G CONSULTING

Lobbying for SHEPHERD THERAPEUTICS · rare cancer R&D

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · posted Jan 20, 2026

Lobbying activity 4

Health Issues

regarding funding and awareness of rare cancers

Defense

regarding funding and awareness of rare cancers

Veterans

regarding funding and awareness of rare cancers

Budget/Appropriations

regarding funding and awareness of rare cancers

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.